Aurobindo Pharma gets FDA nod for Sertraline Hydrochloride
MUMBAI, Nov 7 (Reuters) - Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) on Friday said it got final approval from the U.S. Food and Drug Administration to make and market a 20 mg dose of Sertraline Hydrochloride.
Sertraline is the generic equivalent of Pfizer's (PFE.N: Quote, Profile, Research) Zoloft used for the treatment of depressive disorder in adults.
(Reporting by Aniruddha Basu; Editing by Prem Udayabhanu)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India. Full Coverage
GLOBAL RECOVERY
Global economy in holding pattern - IMF
The global economy is in a holding pattern and vulnerable to more upheaval, the head of the IMF said, adding a lasting recovery will depend on policymakers taking the proper steps in the coming months. Full Article
India
US
UK
